Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deaths
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1871 (Published 27 August 2024) Cite this as: BMJ 2024;386:q1871- Ingrid Torjesen
- London
All products of a brand of microdosing, mushroom infused confectionery called Diamond Shruumz that are available in the US have been recalled and withdrawn from sale after they were linked to 145 illnesses across 29 states, including 59 hospital admissions and two potential deaths.
Diamond Shruumz produces a range of chocolate bars, cones, and gummies that it markets as “an artisan treat for the alternative set.” The confectionery contains a “primo proprietary blend of nootropic and functional mushrooms,” which …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.